COVI-MSC

Sorrento Therapeutics, Inc.

Application Filed: 2020-12-12

Trademark Application Details

Mark For: COVI-MSC™ trademark registration is intended to cover the categories of mesenchymal stem cells for medical purposes for use in the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations for human use, namely, Mesenchymal stem cells for medical or clinical use for the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations featuring Mesenchymal stem cells for the treatment and prevention of infectious diseases, namely, COVID-19 and Coronaviruses. [all]

Status

2022-12-31 UTC

DEAD APPLICATION Refused Dismissed or Invalidated

This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.

Research	OneLook Acronym Finder
Serial Number	90377744
Mark Literal Elements	COVIMSC
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	INTENT TO USE SECTION 2022-03-29
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Lindsay J. Hulley
Attorney Docket Number	035359.0039T

Timeline

2020-12-12	Application Filed
2020-12-16	Location: NEW APPLICATION PROCESSING
2020-12-16	Status: Live/Pending
2020-12-16	Transaction Date
2022-02-01	Published
2022-03-29	Location: INTENT TO USE SECTION
2022-10-31	Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume

Trademark Parties (Applicants & Owners)

Party:	Sorrento Therapeutics, Inc.
Address	4955 Directors Place San Diego, CALIFORNIA UNITED STATES 92121
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Application		2020-12-12
Drawing		2020-12-12
summary-SearchSummary202104271206548900400670		2021-04-27
Non-Final Action		2021-05-04
Amended Drawing		2021-11-01
Drawing		2021-11-01
Response to Office Action		2021-11-01
Amendment and Mail Process Complete		2021-11-03
Response to Office Action		2021-11-04
Amendment and Mail Process Complete		2021-11-06
TRAM Snapshot of App at Pub for Oppostn		2021-12-30
Notice of Publication		2022-01-12
Notification Of Notice of Publication		2022-01-12
OG Publication Confirmation		2022-02-01
Notice of Allowance		2022-03-29
Notice of Abandonment		2022-10-31
ITU Unit Action		2022-11-01

Attorney of Record

LINDSAY J. HULLEY
RUTAN & TUCKER, LLP
18575 JAMBOREE ROAD
9TH FLOOR
IRVINE, CA 92612

Good, Services, and Codes

(ABANDONED)
IC 005. US 005 006 018 044 046 051 052. G & S: Mesenchymal stem cells for medical purposes for use in the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations for human use, namely, Mesenchymal stem cells for medical or clinical use for the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations featuring Mesenchymal stem cells for the treatment and prevention of infectious diseases, namely, COVID-19 and Coronaviruses

International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052

Type Code	Type
GS0051	Stem cells for medical purposes; Pharmaceutical preparations for human use, namely stem cells for medical or clinical use; Pharmaceutical preparations for the treatment and prevention of infectious diseases and COVID-19/Coronavirus

Trademark Filing History

Description	Date	Proceeding Number
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED	2022-10-31
ABANDONMENT - NO USE STATEMENT FILED	2022-10-31	99999
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2022-03-29
PUBLISHED FOR OPPOSITION	2022-02-01
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2022-02-01
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2022-01-12
APPROVED FOR PUB - PRINCIPAL REGISTER	2021-12-29
TEAS/EMAIL CORRESPONDENCE ENTERED	2021-11-05	88889
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2021-11-04
CORRESPONDENCE RECEIVED IN LAW OFFICE	2021-11-04	88889
TEAS/EMAIL CORRESPONDENCE ENTERED	2021-11-02	88889
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2021-11-01
CORRESPONDENCE RECEIVED IN LAW OFFICE	2021-11-01	88889
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2021-05-04
NON-FINAL ACTION WRITTEN	2021-05-04	72008
NON-FINAL ACTION E-MAILED	2021-05-04
ASSIGNED TO EXAMINER	2021-04-27	72008
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2021-02-20
NEW APPLICATION ENTERED IN TRAM	2020-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.